Dimak Chand Sahu, Girendra Kumar Gautam, Durga Prasad Panda, Mohd. Akhtar Rasool
Dimak Chand Sahu1, Girendra Kumar Gautam2*, Durga Prasad Panda3, Mohd. Akhtar Rasool4
1Research Scholar, Department of Pharmacy, Bhagwant University, Ajmer (R.J.), India.
2Director, Shri Ram College of Pharmacy, Muzaffarnagar, U.P. 251001.
3Director Cum Principal and Professor, J.K. College of Pharmacy, Bilaspur (C.G.), India.
4Associate Professor, J.K. College of Pharmacy, Bilaspur (C.G.), India.
Volume - 15,
Issue - 7,
Year - 2022
The percentage of patients with diseases such as cancer, apoplexy, osteoporosis, hypertension, and type 2 diabetes mellitus has been growing exponentially in recent decades. A way of living related illness, type 2 diabetes, is recognised as a serious illness. It is a group of metabolic disorders marked by hyperglycemia due to insulin secretion abnormalities, insulin action faults, or both. There have been different types of diabetes pharmaceuticals used. We have been designing anti-diabetic metal complexes as new candidates, since the relationship between diabetes and biometals such as vanadium, copper, and zinc ions has been recognised for many years. Many zinc(II)(Zn) complexes have been found to have glucose-lowering activity in the treatment of type 2 diabetes. In type 2 diabetic patients, high concentrations of salicylate have been recognised to reverse hyperglycemia. These results strongly suggest that synergism in the treatment of type 2 diabetes is achieved by the cumulative use of Zn and salicylate. Since aspirin, acetyl salicylic acid, has the capacity to chelate, we used this as a Zn ligand. The present study aim to prepare and evaluate the effect of Zn-Aspirin Coordination Metal Complex on Hyperglycaemic activity by Fructose induced diabetes on Wistar rat model for this Several complexes of Zn-salicylate were prepared and their Hyperglycemic activity was determined by performing different screening test and by statistical analysis.
Cite this article:
Dimak Chand Sahu, Girendra Kumar Gautam, Durga Prasad Panda, Mohd. Akhtar Rasool. A Study of Hyperglycaemic activity by Fructose induced diabetes on Wistar rat model by using Zn-Aspirin Coordination Metal Complex. Research Journal of Pharmacy and Technology. 2022; 15(7):3009-4. doi: 10.52711/0974-360X.2022.00502
Dimak Chand Sahu, Girendra Kumar Gautam, Durga Prasad Panda, Mohd. Akhtar Rasool. A Study of Hyperglycaemic activity by Fructose induced diabetes on Wistar rat model by using Zn-Aspirin Coordination Metal Complex. Research Journal of Pharmacy and Technology. 2022; 15(7):3009-4. doi: 10.52711/0974-360X.2022.00502 Available on: https://rjptonline.org/AbstractView.aspx?PID=2022-15-7-24
1. Santhosh Kumar V, Praveen D. Sugar and Chronic Diseases. Research J. Pharm. and Tech. 2016; 9(6): 650-654.
2. Vijay VR , Samundy Kumbhakar. A Descriptive Study to assess the Lifestyle Practices of Diabetic Patients with Respect to Glycemic Control. Asian J. Nur. Edu. and Research. 2016; 6(4): 429-432.
3. Kanase KG, Shinde NV, Bharti DK, Undale VR, Bhosale AV. Diabetes Macroangiopathy- A Review. Research J. Pharmacology and Pharmacodynamics. 2009; 1(2): 45-49.
4. Chinmaya Keshari Sahoo, Surepalli Ram Mohan Rao, Muvvala Sudhakar, Kokkula Satyanarayana. Development and Evaluation of Controlled Release Formulation of Zidovudine Based on Microporous Osmotic Tablet Technology Using Fructose as Osmogen. Research J. Pharm. and Tech. 2017; 10(5): 1459-1470.
5. M.H.R.K. Gupatha. Bayya, Kishan Prasad H.L, Sachidananda Adiga M.N, Usha Sachidanada Adiga. Combined effects of E. Jambolana and C. zeylanicum extract in insulin resistance associated Structural and Functional Hepatic changes in high Fructose-fed rats. Research J. Pharm. and Tech. 2019; 12(12): 5765-5772.
6. Varadharajan Madhavan AM, Lalitha DS and Yoganarasimhan S. Studies on anti-hyperglycemic effect of Euphorbia antiquorum L. root in diabetic rats. Journal of intercultural ethnopharmacology. 2015; 4(4): 308.
7. I Srivallika, P Shivasri, M Ramesh, P Jony Basha, T Vinay Kumar, B Ram Sarath Kumar, D Rajesh Kumar. Evaluation of Anti-Hyperglycaemic Activity of Polyherbal Formulation by using In-Vitro Methods. Research Journal of Pharmacology and Pharmacodynamics. 2014; 6(1): 36-40.
8. Shahraki S, Shiri F and Saeidifar M. Synthesis, characterization, in silico ADMET prediction, and protein binding analysis of a novel zinc (II) Schiff-base complex: Application of multi-spectroscopic and computational techniques. Journal of Biomolecular Structure and Dynamics. 2018; 36(7): 1666-80.
9. Mohd. Yaqub Khan, Poonam Gupta, Bipin Bihari, Vikas Kumar Verma. A Review on Diabetes and Its Management. Asian J. Pharm. Res. 2013; 3(1): 27-32.
10. Ealovega MW, Tabaei BP, Brandle M, Burke R and Herman WH. Opportunistic screening for diabetes in routine clinical practice. Diabetes Care. 2004; 27(1): 9-12.
11. Janka HU, Standl E and Mehnert H. Peripheral vascular disease in diabetes mellitus and its relation to cardiovascular risk factors: screening with the Doppler ultrasonic technique. Diabetes care. 1980; 3(2): 207-13.
12. Bokov D.O., Kulaeva I.R., Potanina O.G., Sergunova E.V., Bondar A.A., Evgrafov A.A., Antsyshkina A.M., Krasnyuk I.I.. Carbohydrates determination in the Snowdrops (Galanthus L.) herbal pharmaceutical substances by TLC and UV-Spectrophotometry. Research J. Pharm. and Tech. 2020; 13(1): 243-249.
13. Harrigan GG, LaPlante RH, Cosma GN, Cockerell G, Goodacre R, Maddox JF, Luyendyk JP, Ganey PE and Roth RA. Application of high-throughput Fourier-transform infrared spectroscopy in toxicology studies: contribution to a study on the development of an animal model for idiosyncratic toxicity. Toxicology letters. 2004; 146(3): 197-205.
14. Jebaseelan S, Ramasubramanian P. Screening of Madhuca indica for Antidiabetic Activity in Alloxan Induced Diabetic Rats. Research J. Pharm. and Tech. 2014; 7(2): 188-190.
15. Mahadeva Rao US, Shanmuga Sundaram C., Srinivasan S. Gymnemic acid mitigates hyperglycemia by attenuating the hepatic glucose metabolic enzymes in high fat diet fed-low dose streptozotocin- induced experimental rodents.